Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
33.75
-1.30 (-3.71%)
At close: Mar 13, 2026, 4:00 PM EDT
33.76
+0.01 (0.03%)
After-hours: Mar 13, 2026, 7:42 PM EDT
Bruker Employees
Bruker had 11,085 employees as of December 31, 2025. The number of employees decreased by 311 or -2.73% compared to the previous year.
Employees
11,085
Change (1Y)
-311
Growth (1Y)
-2.73%
Revenue / Employee
$310,014
Profits / Employee
-$2,030
Market Cap
5.14B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,085 | -311 | -2.73% |
| Dec 31, 2024 | 11,396 | 1,689 | 17.40% |
| Dec 31, 2023 | 9,707 | 1,182 | 13.87% |
| Dec 31, 2022 | 8,525 | 760 | 9.79% |
| Dec 31, 2021 | 7,765 | 365 | 4.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Penumbra | 4,700 |
| LivaNova | 3,300 |
| Haemonetics | 3,023 |
| iRhythm Holdings | 2,400 |
BRKR News
- 18 days ago - Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR - Business Wire
- 19 days ago - Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications - Business Wire
- 20 days ago - Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum - Business Wire
- 20 days ago - Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology - Business Wire
- 4 weeks ago - These Analysts Cut Their Forecasts On Bruker Following Q4 Results - Benzinga
- 4 weeks ago - Bruker Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 4 weeks ago - Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - Business Wire
- 4 weeks ago - Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration - Business Wire